3515 LYMAN BOULEVARD, CHASKA, MN
Lifecore Biomedical, Inc. Announces Redemption of Series A Preferred Stock
Approval of Lifecore Biomedical, Inc. 2026 Stock Incentive Plan
Reports Financial Results for the First Quarter Ended March 31, 2026, and Provides Corporate Update
Reports Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, and Provides Corporate Update
Shareholder Director Nominations
Lifecore Biomedical, Inc. Adopts Incentive Bonus Plan for Executives
Investor Presentation
Reports Financial Results for the Three Months Ended September 30, 2025, and Provides Corporate Update
Q3
Annual Report Transition
Q1
FY 2025
Q2
FY 2024
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Amended Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload